Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.955 USD | -4.63% | -6.03% | -20.43% |
May. 30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
May. 30 | INmune Bio to Join Russell 3000 Index in July | MT |
Financials (USD)
Sales 2024 * | 28K | Sales 2025 * | 29K | Capitalization | 186M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -51M | EV / Sales 2024 * | 6,634 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6,405 x |
P/E ratio 2024 * |
-3.49
x | P/E ratio 2025 * |
-3.68
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.8% |
Latest transcript on INmune Bio, Inc.
1 day | +1.84% | ||
1 week | -2.69% | ||
Current month | -0.63% | ||
1 month | -18.84% | ||
3 months | -22.84% | ||
6 months | -0.27% | ||
Current year | -16.61% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 8.96 | -4.58% | 63 606 |
24-06-05 | 9.39 | +2.18% | 85,605 |
24-06-04 | 9.19 | -4.57% | 75,850 |
24-06-03 | 9.63 | +1.90% | 114,043 |
24-05-31 | 9.45 | -0.89% | 61,224 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.61% | 186M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.28% | 22.67B | |
-10.16% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- INMB Stock